Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1978 2
1979 2
1980 2
1981 4
1983 8
1984 2
1985 3
1986 13
1987 9
1988 10
1989 11
1990 9
1991 12
1992 9
1993 9
1994 3
1995 11
1996 23
1997 13
1998 11
1999 7
2000 9
2001 8
2002 9
2003 5
2004 8
2005 12
2006 15
2007 19
2008 10
2009 4
2010 10
2011 13
2012 9
2013 6
2014 8
2015 9
2016 10
2017 12
2018 12
2019 2
2020 8
2021 3
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

356 results

Results by year

Filters applied: . Clear all
Page 1
ETAP changes.
Vermeulen NP, Seegal RF, Koeman JH. Vermeulen NP, et al. Environ Toxicol Pharmacol. 2001 Jun;10(1-2):V. doi: 10.1016/s1382-6689(01)00086-2. Environ Toxicol Pharmacol. 2001. PMID: 11382557 No abstract available.
Editorial.
Koeman JH, Vermeulen NP. Koeman JH, et al. Among authors: vermeulen np. Environ Toxicol Pharmacol. 2000 Jan 1;8(2):71. doi: 10.1016/s1382-6689(00)00043-0. Environ Toxicol Pharmacol. 2000. PMID: 10867364 No abstract available.
Editorial.
Koeman JH, Vermeulen NP. Koeman JH, et al. Among authors: vermeulen np. Environ Toxicol Pharmacol. 1996 Feb 15;1(1):v. doi: 10.1016/s1382-6689(96)90001-0. Environ Toxicol Pharmacol. 1996. PMID: 21781656 No abstract available.
Cytochromes P450 and drug resistance.
Doehmer J, Goeptar AR, Vermeulen NP. Doehmer J, et al. Among authors: vermeulen np. Cytotechnology. 1993;12(1-3):357-66. doi: 10.1007/BF00744673. Cytotechnology. 1993. PMID: 7764457 Review.
[No title available]
Rietjens IM, Vermeulen NP. Rietjens IM, et al. Among authors: vermeulen np. Environ Toxicol Pharmacol. 2002 Jul;11(3-4):147. doi: 10.1016/s1382-6689(02)00012-1. Environ Toxicol Pharmacol. 2002. PMID: 21782596 No abstract available.
Enzyme-catalyzed activation of anticancer prodrugs.
Rooseboom M, Commandeur JN, Vermeulen NP. Rooseboom M, et al. Among authors: vermeulen np. Pharmacol Rev. 2004 Mar;56(1):53-102. doi: 10.1124/pr.56.1.3. Pharmacol Rev. 2004. PMID: 15001663 Review.
Cytochrome p450 in silico: an integrative modeling approach.
de Graaf C, Vermeulen NP, Feenstra KA. de Graaf C, et al. Among authors: vermeulen np. J Med Chem. 2005 Apr 21;48(8):2725-55. doi: 10.1021/jm040180d. J Med Chem. 2005. PMID: 15828810 Review. No abstract available.
Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
Autrup H, Barile FA, Berry SC, Blaauboer BJ, Boobis A, Bolt H, Borgert CJ, Dekant W, Dietrich D, Domingo JL, Gori GB, Greim H, Hengstler J, Kacew S, Marquardt H, Pelkonen O, Savolainen K, Heslop-Harrison P, Vermeulen NP. Autrup H, et al. Among authors: vermeulen np. Toxicol Lett. 2020 Oct 1;331:259-264. doi: 10.1016/j.toxlet.2020.04.008. Epub 2020 Apr 30. Toxicol Lett. 2020. PMID: 32360654 No abstract available.
356 results